Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 15Carcinoma, Non-Small-Cell Lung 6Neoplasms 4Uveal Melanoma 3Sarcoma 3Prostatic Neoplasms 3Neoplasm Metastasis 3Pancreatic Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Diseases 1Osteosarcoma 1Neoplastic Cells, Circulating 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Metastatic Microsatellite Stable Colorectal Cancer 1Kidney Neoplasms 1Hypoxia 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1

Interventions

Radiotherapy 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Metastatic Microsatellite Stable Colorectal Cancer × Ipilimumab × Clear all
NCT04575922 2022-09-08

Nivolumab+Ipilimumab+RT in MSS mCRC

Massachusetts General Hospital

Phase 2 Unknown
32 enrolled
Gastrointestinal

Metastatic Microsatellite Stable Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡